Skip to main content
OpenTrials
Completed

NCT Number: NCT04587063

Evaluation of Emails Promoting Mail-order Pharmacy

In this evaluation, four versions of emails will be sent to eligible health plan members who are not currently enrolled in the health system's mail-order pharmacy. A control group will not receive any communication. The researchers hypothesize that the use of content informed by behavioral nudge theory in the emails should lead to increased enrollment in the health system's mail-order pharmacy.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Geisinger

Danville, Pennsylvania, 17822, United States

About this study

The utilization of a mail-order pharmacy can increase adherence to medications. The health system's mail-order pharmacy (from here, simply referred to as mail-order pharmacy) can also provide reduced costs for medications. Ongoing outreach efforts involve sending emails and other communications encouraging enrollment in Geisinger's mail-order pharmacy to eligible members of the system's health plan (i.e., those who take maintenance medications). The study will compare a standard promotional email from these outreach efforts, as well as three new emails with content informed by behavioral science research, against a no-contact control arm and each other.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • An active member of the health plan (Medicare, Commercial, or Exchange)
  • Currently prescribed maintenance medications
  • Not currently subscribed to the health system's mail-order pharmacy
  • Has an email on record

Exclusion criteria

  • Explicitly opted out of receiving emails from the health system
  • Only has eligible current prescriptions for fewer than 28 days
  • Only has prescriptions that cannot be sent via mail-order pharmacy (e.g., antidepressants, specialty-tier drugs)
  • Is a Medicare member in the coverage gap
  • Shares an email address with another selected participant (who was randomly chosen for inclusion among all those sharing the same email address)

Treatment and study plan

Fear Appeals

Behavioral

Email

Message about Future Healthcare Costs

Behavioral

Email

Endorsement from a Doctor

Behavioral

Email

Comparison Table

Behavioral

Email

Highlighting Cost Savings and Convenience

Behavioral

Email

Primary outcomes

  1. Mail-order Pharmacy Enrollment

    Time frame: 1 week from the intervention

    Binary variable indicating if there was an enrollment in the health system's mail order pharmacy

Secondary outcomes

  1. Email Opens

    Time frame: 1 week from the intervention

    Binary variable indicating if the email was opened

  2. Email Link Click

    Time frame: 1 week from the intervention

    Binary variable indicating if the link to the mail-order pharmacy website was clicked

  3. Email Unsubscribes

    Time frame: 1 week from the intervention

    Binary variable indicating if the recipient requested to unsubscribe from receiving emails from the health system

Sponsors and collaborators

Lead sponsor

Geisinger Clinic

Other

Registry information

Official study title

Evaluation of an Email Intervention Promoting Enrollment in Mail-order Pharmacy

Important dates

Study start
2020
Primary completion
2020
Study completion
2020
First posted
Oct 14, 2020
Registry last updated
Oct 27, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.